Literature DB >> 9116173

Membrane components separate early-onset Alzheimer's disease from senile dementia of the Alzheimer type.

C G Gottfries1, I Karlsson, L Svennerholm.   

Abstract

Brain tissue from 12 subjects with pure Alzheimer's disease (AD) and 21 subjects with senile dementia of the Alzheimer type (SDAT) was investigated for membrane lipids and compared with that in age-matched controls. In brain tissue from the patients with AD, phospholipids were significantly decreased compared with that from SDAT patients and controls, cholesterol was reduced compared with that in controls, and gangliosides were significantly reduced in all gray-matter areas investigated compared with those in both SDAT subjects and controls. A reduction in gangliosides also occurred in the SDAT group, but it was smaller. In the white matter, the pattern of changes was the opposite. Phospholipids, cholesterol, cerebroside, and sulfatide were significantly reduced in the frontal-lobe white matter in the SDAT group compared with that in age-matched controls and AD patients. Gangliosides in the cerebrospinal fluid also separated AD from SDAT and controls. The findings indicate synapse degeneration as an important pathogenetic factor in AD. This disorder should be separated from SDAT, in which white-matter degeneration appears to be more prominent.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9116173     DOI: 10.1017/s1041610296002736

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  23 in total

1.  Dysfunctional pro-ceramide, ER stress, and insulin/IGF signaling networks with progression of Alzheimer's disease.

Authors:  Suzanne M de la Monte; Edward Re; Lisa Longato; Ming Tong
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Apolipoprotein serum amyloid A down-regulates smooth-muscle cell lipid biosynthesis.

Authors:  B M Schreiber; M Veverbrants; R E Fine; J K Blusztajn; M Salmona; A Patel; J D Sipe
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

3.  Myelin injury and degraded myelin vesicles in Alzheimer's disease.

Authors:  Xinhua Zhan; Glen C Jickling; Bradley P Ander; Dazhi Liu; Boryana Stamova; Christopher Cox; Lee-Way Jin; Charles DeCarli; Frank R Sharp
Journal:  Curr Alzheimer Res       Date:  2014-03       Impact factor: 3.498

4.  Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex.

Authors:  Miki Igarashi; Kaizong Ma; Fei Gao; Hyung-Wook Kim; Stanley I Rapoport; Jagadeesh S Rao
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

5.  Displacement currents associated with the insertion of Alzheimer disease amyloid beta-peptide into planar bilayer membranes.

Authors:  J Vargas; J M Alarcón; E Rojas
Journal:  Biophys J       Date:  2000-08       Impact factor: 4.033

6.  Altered temporal lobe white matter lipid ion profiles in an experimental model of sporadic Alzheimer's disease.

Authors:  Ming Tong; Raiane Leão; Gina V Vimbela; Emine B Yalcin; Jared Kay; Alexander Krotow; Suzanne M de la Monte
Journal:  Mol Cell Neurosci       Date:  2017-04-21       Impact factor: 4.314

Review 7.  Alzheimer's disease as homeostatic responses to age-related myelin breakdown.

Authors:  George Bartzokis
Journal:  Neurobiol Aging       Date:  2009-09-22       Impact factor: 4.673

8.  Ablation of the locus coeruleus increases oxidative stress in tg-2576 transgenic but not wild-type mice.

Authors:  Orest Hurko; Kurt Boudonck; Cathleen Gonzales; Zoe A Hughes; J Steve Jacobsen; Peter H Reinhart; Daniel Crowther
Journal:  Int J Alzheimers Dis       Date:  2010-10-11

9.  Deregulation of sphingolipid metabolism in Alzheimer's disease.

Authors:  Xingxuan He; Yu Huang; Bin Li; Cheng-Xin Gong; Edward H Schuchman
Journal:  Neurobiol Aging       Date:  2008-06-10       Impact factor: 4.673

Review 10.  ApoE-dependent plasticity in Alzheimer's disease.

Authors:  Bruce Teter
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.